Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 279

1.

Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.

Rostaing L, Bunnapradist S, Griny├│ JM, Ciechanowski K, Denny JE, Silva HT Jr, Budde K; Envarsus Study Group..

Am J Kidney Dis. 2016 Apr;67(4):648-59. doi: 10.1053/j.ajkd.2015.10.024. Epub 2015 Dec 22.

2.

New-Onset Diabetes After Transplantation: Results From a Double-Blind Early Corticosteroid Withdrawal Trial.

Pirsch JD, Henning AK, First MR, Fitzsimmons W, Gaber AO, Reisfield R, Shihab F, Woodle ES.

Am J Transplant. 2015 Jul;15(7):1982-90. doi: 10.1111/ajt.13247. Epub 2015 Apr 16.

3.

Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial.

Weir MR, Gravens-Muller L, Costa N, Ivanova A, Manitpisitkul W, Bostom AG, Diamantidis CJ; FAVORIT Study Investigators..

Transplantation. 2015 May;99(5):1003-8. doi: 10.1097/TP.0000000000000454.

4.

Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial.

Budde K, Bunnapradist S, Grinyo JM, Ciechanowski K, Denny JE, Silva HT, Rostaing L; Envarsus study group..

Am J Transplant. 2014 Dec;14(12):2796-806. doi: 10.1111/ajt.12955. Epub 2014 Oct 2.

5.

Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients.

Brokhof MM, Sollinger HW, Hager DR, Muth BL, Pirsch JD, Fernandez LA, Bellingham JM, Mezrich JD, Foley DP, D'Alessandro AM, Odorico JS, Mohamed MA, Vidyasagar V, Ellis TM, Kaufman DB, Djamali A.

Transplantation. 2014 Mar 27;97(6):612-7. doi: 10.1097/TP.0000000000000031.

6.

Outcomes of Clostridium difficile infection in recipients of solid abdominal organ transplants.

Hsu JL, Enser JJ, McKown T, Leverson GE, Pirsch JD, Hess TM, Safdar N.

Clin Transplant. 2014 Feb;28(2):267-73. doi: 10.1111/ctr.12309. Epub 2014 Jan 30.

7.

Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes.

Niederhaus SV, Leverson GE, Lorentzen DF, Robillard DJ, Sollinger HW, Pirsch JD, Torrealba JR, Odorico JS.

Am J Transplant. 2013 Nov;13(11):2945-55. doi: 10.1111/ajt.12443. Epub 2013 Sep 19.

8.

Serum ╬▓2-microglobulin at discharge predicts mortality and graft loss following kidney transplantation.

Astor BC, Muth B, Kaufman DB, Pirsch JD, Michael Hofmann R, Djamali A.

Kidney Int. 2013 Oct;84(4):810-7. doi: 10.1038/ki.2013.172. Epub 2013 May 8.

PMID:
23657143
9.

Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients.

Djamali A, Muth BL, Ellis TM, Mohamed M, Fernandez LA, Miller KM, Bellingham JM, Odorico JS, Mezrich JD, Pirsch JD, D'Alessandro TM, Vidyasagar V, Hofmann RM, Torrealba JR, Kaufman DB, Foley DP.

Kidney Int. 2013 Jun;83(6):1185-92. doi: 10.1038/ki.2013.44. Epub 2013 Feb 27.

10.

Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal.

Gaber AO, Moore LW, Alloway RR, Woodle ES, Pirsch J, Shihab F, Henning A, Fitzsimmons W, Holman J, Reisfield R, First MR; Astellas Corticosteroid Withdrawal Study Group..

Transplantation. 2013 Feb 27;95(4):573-9. doi: 10.1097/TP.0b013e3182777efb.

PMID:
23423269
11.

Native kidney function following liver transplantation using calcineurin inhibitors: single-center analysis with 20 years of follow-up.

LaMattina JC, Mezrich JD, Fernandez LA, D'Alessandro AM, Djamali A, Musat AI, Pirsch JD, Foley DP.

Clin Transplant. 2013 Mar-Apr;27(2):193-202. doi: 10.1111/ctr.12063. Epub 2013 Jan 7.

12.

Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial.

Bunnapradist S, Ciechanowski K, West-Thielke P, Mulgaonkar S, Rostaing L, Vasudev B, Budde K; MELT investigators..

Am J Transplant. 2013 Mar;13(3):760-9. doi: 10.1111/ajt.12035. Epub 2012 Dec 21.

13.

Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study.

Shihab FS, Lee ST, Smith LD, Woodle ES, Pirsch JD, Gaber AO, Henning AK, Reisfield R, Fitzsimmons W, Holman J; M. R. First for the Astellas Corticosteroid Withdrawal Group..

Am J Transplant. 2013 Feb;13(2):474-84. doi: 10.1111/j.1600-6143.2012.04327.x. Epub 2012 Nov 21.

14.

Complications associated with liver transplantation in the obese recipient.

LaMattina JC, Foley DP, Fernandez LA, Pirsch JD, Musat AI, D'Alessandro AM, Mezrich JD.

Clin Transplant. 2012 Nov-Dec;26(6):910-8. doi: 10.1111/j.1399-0012.2012.01669.x. Epub 2012 Jun 13.

15.

Differential outcomes of expanded-criteria donor renal allografts according to recipient age.

Mezrich JD, Pirsch JD, Fernandez LA, Foley DP, Bellingham JM, Odorico JS, Leverson GE, Munoz-Del-Rio A, Sollinger HW, Kaufman DB, D'Alessandro AM.

Clin J Am Soc Nephrol. 2012 Jul;7(7):1163-71. doi: 10.2215/CJN.00150112. Epub 2012 May 31.

16.

Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease, and allograft failure late after kidney transplant.

Israni AK, Snyder JJ, Skeans MA, Kasiske BL; PORT Investigators..

Transpl Int. 2012 Jul;25(7):748-57. doi: 10.1111/j.1432-2277.2012.01488.x. Epub 2012 Apr 30.

17.

Alemtuzumab as compared to alternative contemporary induction regimens.

LaMattina JC, Mezrich JD, Hofmann RM, Foley DP, D'Alessandro AM, Sollinger HW, Pirsch JD.

Transpl Int. 2012 May;25(5):518-26. doi: 10.1111/j.1432-2277.2012.01448.x. Epub 2012 Mar 6.

18.

The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience.

Singh N, Neidlinger N, Djamali A, Leverson G, Voss B, Sollinger HW, Pirsch JD.

Clin Transplant. 2012 Sep-Oct;26(5):684-93. doi: 10.1111/j.1399-0012.2011.01583.x. Epub 2012 Jan 29.

PMID:
22283142
19.

Long-term pancreatic allograft survival after renal retransplantation in prior simultaneous pancreas-kidney recipients.

Lamattina J, Sollinger H, Becker Y, Mezrich J, Pirsch J, Odorico J.

Am J Transplant. 2012 Apr;12(4):937-46. doi: 10.1111/j.1600-6143.2011.03916.x. Epub 2012 Jan 10.

20.

Pretransplant immune regulation predicts allograft outcome: bidirectional regulation correlates with excellent renal transplant function in living-related donor-recipient pairs.

Jankowska-Gan E, Sheka A, Sollinger HW, Pirsch JD, Hofmann RM, Haynes LD, Armbrust MJ, Mezrich JD, Burlingham WJ.

Transplantation. 2012 Feb 15;93(3):283-90. doi: 10.1097/TP.0b013e31823e46a0.

Supplemental Content

Loading ...
Support Center